Revista de la Universidad Industrial de Santander Salud最新文献

{"title":"Relationship between handgrip strength and inspiratory muscles with the success of the spontaneous breathing trial","authors":"Esther Wilches-Luna, Leonardo Arzayus","doi":"10.18273/saluduis.55.e:23066","DOIUrl":"https://doi.org/10.18273/saluduis.55.e:23066","url":null,"abstract":"Introduction: In critically ill patients on mechanical ventilation, the loss of inspiratory and peripheral muscle strength is associated with prolonged mechanical ventilation and failed weaning. Objective: To determine the relationship between handgrip strength and inspiratory muscle strength with the success of the Spontaneous Breathing Trial in adults with ventilatory support greater than 48 hours. Methodology: Prospective observational cross-sectional study performed at a tertiary hospital in Colombia. Handgrip strength and Maximal Inspiratory Pressure were measured once a day before Spontaneous Breathing Trial testing. Pearson’s test and Cohen’s D test were used to analyze correlations. Results: A total of 51 patients were included, 57% male, with a mean age of 51.9±20 years. A positive correlation was identified between Maximal Inspiratory Pressure and grip strength; and a negative correlation between grip strength and Maximal Inspiratory Pressure with the days of stay in the intensive care unit, (r -0.40; p<0.05) and (r -0.45; p<0.05). Conclusions: Handgrip strength and Maximal Inspiratory Pressure were positively correlated with Spontaneous Breathing Trial success. The importance of these measures to guide ventilator disconnection processes is highlighted.","PeriodicalId":31194,"journal":{"name":"Revista de la Universidad Industrial de Santander Salud","volume":"3 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136377852","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The practical irrelevance of distinguishing between public health and population health","authors":"Jose Moreno-Montoya","doi":"10.18273/saluduis.55.e:23065","DOIUrl":"https://doi.org/10.18273/saluduis.55.e:23065","url":null,"abstract":"Recently Idrovo AJ editorialized on an ongoing debate about the differentiation between public health and population health1 , regarding environmental health determinants. While he argued for the distinctiveness of these terms, or at least, of those points of view, it can be contended that from a practical standpoint, such distinctions are not needed. As has been reported before, several authors have declared population health as a relatively new term, with no agreement as to whether it refers to a concept of health or a field of study of health determinants and promoting the debate, sometimes heated, about whether population health and public health are identical or different2. This response to the editor aims to highlight the practical irrelevance of differentiating between public health and population health, emphasizing their shared goals, methodologies, and outcomes.Considering the goals, public health and population health share a fundamental objective: to enhance the health and well-being of communities and populations. The overarching aim is to prevent disease, prolong life, and promote health through various interventions, including policy3 . Both disciplines prioritize the assessment of health needs, the development of strategies for intervention, and the evaluation of health outcomes at the community or population level. As such, differentiating between the two becomes redundant when considering their core mission. However, some authors have emphasized about population health in terms of health determination specifically, about how system-level variables influence the health of populations4.","PeriodicalId":31194,"journal":{"name":"Revista de la Universidad Industrial de Santander Salud","volume":"16 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136023673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La estadística en los programas universitarios en ciencias de la salud: Un elemento importante para la formación de investigadores en América Latina","authors":"Brian Johan Bustos-Viviescas, Carlos Enrique García-Yerena, Amalia Villamizar-Navarro, Andrea del Pilar Lizcano-Sánchez, John Alexander García-Galviz","doi":"10.18273/saluduis.55.e:23061","DOIUrl":"https://doi.org/10.18273/saluduis.55.e:23061","url":null,"abstract":"","PeriodicalId":31194,"journal":{"name":"Revista de la Universidad Industrial de Santander Salud","volume":"75 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136023675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La enfermera de enlace: revisión de su actuación en la continuidad del cuidado","authors":"Danelia Gómez-Torres, Karla Sofía Gómez-Alcántara","doi":"10.18273/saluduis.55.e:23058","DOIUrl":"https://doi.org/10.18273/saluduis.55.e:23058","url":null,"abstract":"Introducción: la enfermera de enlace no es de aparición reciente, sus funciones se han diversificado posicionándose como una profesionista importante en el proceso de alta hospitalaria, el objetivo de la revisión es identificar la actuación de la enfermera de enlace en la continuidad del cuidado a los pacientes tras su alta hospitalaria. Materiales y métodos: revisión integradora realizada en cuatro bases de datos, con publicaciones entre 2010 y 2020, siendo seleccionadas 12 investigaciones. Para la búsqueda se utilizaron los descriptores: alta del paciente, continuidad de la atención al paciente, cuidado de transición, gestores de casos, perfil laboral y práctica profesional. Resultados: la enfermera de enlace actúa hacia la planificación del alta hospitalaria, gestión de recursos y vínculo del sistema de salud. Conclusiones: las enfermeras de enlace actúan hacia un modelo de cuidados centrados en el paciente, evitando el cuidado fragmentado, mejorando el flujo de información entre niveles asistenciales, propiciando continuidad.","PeriodicalId":31194,"journal":{"name":"Revista de la Universidad Industrial de Santander Salud","volume":"9 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136361531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Aspectos farmacológicos y adherencia al tratamiento antirretroviral en pacientes VIH","authors":"Carlos Alberto Gómez-Mercado, Juliana Madrigal-Cadavid, Alejandra Rendón-Montoya, Ana María Hincapié, Newar Andrés Giraldo-Álzate, Jorge Iván Estrada-Acevedo","doi":"10.18273/saluduis.55.e:23063","DOIUrl":"https://doi.org/10.18273/saluduis.55.e:23063","url":null,"abstract":"Introducción: la adherencia al tratamiento farmacológico favorece la supresión viral y reduce la resistencia a la terapia antirretroviral de gran actividad a largo plazo. Objetivo: determinar la relación entre los aspectos farmacológicos y la adherencia al tratamiento antirretroviral de una IPS colombiana. Metodología: estudio analítico transversal en 9835 pacientes con diagnóstico de VIH en tratamiento antirretroviral entre los años 2012 a 2020. Se utilizó un modelo de regresión logística binaria múltiple con fines explicativos. Resultados: la proporción de adherencia fue de 90,04% y en el modelo ajustado se evaluó su relación con los antecedentes de no adherencia (ORa:0,52 IC95%:0,40–0,66), grupo farmacológico (2 ITIAN + 1 IP u otro) (ORa:1,22 IC95%:0,99–1,76), dos tomas al día (ORa:1,02 IC95%:0,74–1,40), unidades al día (≥ 3) (ORa:0,69 IC95%:0,47–1,02), reacciones adversas a medicamentos (ORa:0,56 IC95%:0,40–0,78), polimedicación (ORa:1,36 IC95%:1,00–1,85), tiempo TAR (1 a 2 años) (ORa:1,63 IC95%:1,27–2,09),tiempo TAR (6 a 12 meses) (ORa:1,66 IC95%:1,27–2,18), tiempo TAR (<6 meses) (ORa:1,36 IC95%:1,03–1,78), tasa de reclamación de los medicamentos (ORa:0,42 IC95%:0,32–0,55) y antecedentes PRUM (ORa:0,11 IC95%:0,09–0,14). Conclusión: los antecedentes de no adherencia, reacciones adversas, tasa de reclamación de los medicamentos y antecedentes de problemas relacionados con el uso de medicamentos son aspectos que reducen la probabilidad de adherencia; mientras que el mayor tiempo de uso del tratamiento aumenta la misma.","PeriodicalId":31194,"journal":{"name":"Revista de la Universidad Industrial de Santander Salud","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"136361479","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Miedo a la muerte y a su proceso en personal de pediatría durante la pandemia COVID-19.","authors":"Carlos Enrique Yepes Delgado, César Augusto Vanegas Díaz, Catalina Mesa Muñoz, Gloria Estrada","doi":"10.18273/saluduis.55.e:23037","DOIUrl":"https://doi.org/10.18273/saluduis.55.e:23037","url":null,"abstract":"Introducción: la evidencia obtenida en estudios previos señala que existe mayor ansiedad por el proceso de morir que, por la muerte misma, aunque falta mayor investigación. Objetivo: analizar el miedo a la muerte y al proceso de morir propio y de otros en el servicio de pediatría del Hospital Pablo Tobón Uribe. Metodología: se realizó un estudio analítico transversal con la Escala de Miedo a la Muerte de Collett-Lester en 143 personas: 25,2 % pediatras generales y subespecialistas, 70,6 % profesionales de enfermería y auxiliares, y 4,2 % terapeutas respiratorios. El análisis incluyó estadística descriptiva, pruebas de Chi2, U de Mann-Whitney, Fisher, T de Student, ANOVA y el Alfa de Cronbach. Resultados: los hallazgos del estudio sugieren que es menor el miedo a la propia muerte que el miedo a la muerte de otros, y no hay diferencia entre el miedo al proceso de morir propio y de otros. Es mayor el miedo a la muerte en enfermeras profesionales y menor en pediatras subespecialistas. Existe mayor miedo a la muerte en el servicio de UCI-UCE (media: 3,53 DS: 0,88) comparado con urgencias (media: 2,66 DS: 0,59). Hay asociación entre el miedo a la muerte con: el sexo femenino (p = 0,000), tener una creencia religiosa (p = 0,048), y el cargo (p = 0,007). La escala tuvo muy alta fiabilidad (Alfa de Cronbach: 0,95). Discusión: es de aclarar que este estudio fue realizado durante el segundo año de la pandemia del COVID-19, cuan do había menor temor, mayor conocimiento y vacunas, cuyos resultados se corresponden con otros estudios. Conclusión: en el presente estudio el mayor miedo a la muerte se asoció con ser mujer, tener creencia religiosa y laborar en UCI-UCE comparado con urgencias.","PeriodicalId":31194,"journal":{"name":"Revista de la Universidad Industrial de Santander Salud","volume":"88 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2023-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135116060","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Anticoagulación en pacientes con infección por SARS-CoV-2/COVID-19","authors":"Emilio Abuabara-Franco, Dagoberto Serpa-Díaz, Víctor Leal-Martínez, Nehomar Pájaro-Galvis, José Correa-Guerrero, Jorge-Eduardo Rico-Fontalvo, J. Bohórquez-Rivero, Rodrigo Daza-Arnedo, Jonatan López-Fontalvo, L. Salgado-Montiel, María Raad-Sabaria, Daniel Porto-Valiente","doi":"10.18273/REVSAL.V52N4-2020009","DOIUrl":"https://doi.org/10.18273/REVSAL.V52N4-2020009","url":null,"abstract":"espanolIntroduccion: el COVID-19 es una enfermedad infecciosa ocasionada por el virus RNA SARS-CoV-2, con una alta tasa de contagio y con un curso clinico heterogeneo. Existe evidencia que en fase avanzada de COVID-19 hay un riesgo aumentado de coagulacion intravascular diseminada. Por lo tanto, el manejo con heparinas debe ser considerado como una estrategia terapeutica. Objetivos: nuestro objetivo principal es mostrar la literatura mas relevante disponible, con referencia a la utilidad de la anticoagulacion en el manejo de la hipercoagulabilidad en los pacientes con COVID-19 graves. Metodologia: se realizo una revision narrativa a partir de la busqueda avanzada con los terminos DeSC: Infecciones por Coronavirus; SARS-CoV; Coagulacion Sanguinea; Coagulacion Intravascular Diseminada; Disfuncion organica multiple; Sepsis; Sindrome de respuesta inflamatoria sistemica; Lesion renal aguda. Se utilizaron los motores de busqueda Clinical Key, Embase, PubMed y Ovid, obteniendo un total de 143 resultados, entre articulos originales, reportes de casos, series de casos y revisiones de la literatura, se seleccionaron un total de 56 articulos que fueron utilizados para la elaboracion de la presente revision de tema. Conclusiones: el manejo con heparinas debe ser considerado como una estrategia terapeutica. Continuamos con la necesidad de futuros estudios que indaguen interrogantes en el paciente COVID-19 hospitalizado, especialmente que definan, evaluando riesgo/beneficio, que se justifica o no con respecto a la anticoagulacion plena en algunos pacientes especificos con COVID-19. EnglishIntroduction: COVID-19 is an infectious disease caused by the RNA SARS-CoV-2 virus, with a high rate of infection and a heterogeneous clinical course. There is evidence that in the advanced phase of COVID-19 there is an increased risk of disseminated intravascular coagulation. Therefore, heparin management should be considered as a therapeutic strategy. Objectives: our main objective is to show the most relevant literature available, with reference to the usefulness of anticoagulation in the management of hypercoagulability in patients with COVID-19 and severe manifestations. Methodology: A narrative review was performed from the advanced search with the terms DeSC: Coronavirus Infections; SARS-CoV; Blood Coagulation; Disseminated intravascular coagulation; Multiple organic dysfunction; Sepsis; Systemic inflammatory response syndrome; Acute kidney injury. The Clinical Key, Embase, PubMed and Ovid search engines were used, obtaining a total of 143 results, among original articles, case reports, case series and literature reviews, a total of 56 articles were selected that were used to the preparation of this topic review. Conclusions: Heparin management should be considered as a therapeutic strategy. We continue with the need for future studies that investigate questions in the hospitalized COVID-19 patient, especially defining, evaluating risk / benefit, which is justified or ","PeriodicalId":31194,"journal":{"name":"Revista de la Universidad Industrial de Santander Salud","volume":"52 1","pages":"422-430"},"PeriodicalIF":0.0,"publicationDate":"2020-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41781168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Epidemia por COVID-19 en Colombia: del “pico” de la emergencia a la sostenibilidad de la respuesta","authors":"L. Rodríguez-Villamizar","doi":"10.18273/REVSAL.V52N4-2020014","DOIUrl":"https://doi.org/10.18273/REVSAL.V52N4-2020014","url":null,"abstract":"espanolEl pasado 6 de marzo de 2020 se identifico el primer caso de infeccion por SARS-Cov-2 en Colombia. Luego de seis meses de desarrollo de la epidemia, la mayoria de las ciudades del pais han experimentado un periodo agudo de ascenso de casos y fallecimientos, asi como las consecuencias devastadoras sobre sus economias. En el ambiente nacional y regional se percibe un agotamiento gubernamental y ciudadano por la afectacion de la epidemia en terminos de la cantidad de infectados y fallecidos y por el tiempo transcurrido con las medidas de aislamiento preventivo obligatorio que se prolongaron desde el 25 de marzo hasta el 1 de septiembre en todo el territorio nacional. Sin embargo, estamos todavia lejos de estar cerca del final de la epidemia y en esta nueva etapa se requiere pasar del centralismo de la respuesta inicial a la sostenibilidad de la respuesta regional. EnglishOn March 6, 2020, the first case of SARS-Cov-2 infection was identified in Colombia. After six months of development of the epidemic in Colombia, most cities in the country have experienced an acute period of rise in cases and deaths as well as the devastating consequences on their economies. In the national and regional environment, government and citizen exhaustion is perceived due to the impact of the epidemic in terms of the number of infected and deceased and the time elapsed with the mandatory preventive isolation measures that lasted from March 25 to September 1 throughout the national territory. However, we are still far from being close to the end of the epidemic and in this new stage it is necessary to move from the centrality of the initial response to the sustainability of the regional response","PeriodicalId":31194,"journal":{"name":"Revista de la Universidad Industrial de Santander Salud","volume":"52 1","pages":"462-466"},"PeriodicalIF":0.0,"publicationDate":"2020-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49306986","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lecciones del pasado. ¿podemos aprender algo de las epidemias anteriores?","authors":"J. C. E. Castañeda","doi":"10.18273/REVSAL.V52N4-2020015","DOIUrl":"https://doi.org/10.18273/REVSAL.V52N4-2020015","url":null,"abstract":"Desde el comienzo de la actual pandemia de COVID 19, atribuida a un nuevo agente viral identificado como SARS-CoV-2, la referencia a otras epidemias no se hizo esperar. Ya fuese para resaltar lo novedoso de la actual o, por el contrario, para mostrar las continuidades o reiteraciones en la historia, los sucesos del pasado han estado muy presentes en las reflexiones del ahora. Y no es para menos, dado que la incertidumbre y angustia del presente nos ha puesto en una situacion especial, proclive a buscar ensenanzas tanto en los logros como en las equivocaciones del pasado.","PeriodicalId":31194,"journal":{"name":"Revista de la Universidad Industrial de Santander Salud","volume":"52 1","pages":"468-476"},"PeriodicalIF":0.0,"publicationDate":"2020-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42632953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Más aristas que solo el fraude: el caso de Dololed en Colombia","authors":"Israel Adan Rico Alba","doi":"10.18273/REVSAL.V52N4-2020018","DOIUrl":"https://doi.org/10.18273/REVSAL.V52N4-2020018","url":null,"abstract":"","PeriodicalId":31194,"journal":{"name":"Revista de la Universidad Industrial de Santander Salud","volume":"52 1","pages":"490-491"},"PeriodicalIF":0.0,"publicationDate":"2020-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44903571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}